PIPELINE

0
INDICATIONS

OUR FOCUS

We focus on the development of repurposed small molecule drugs targeting neurological indications facilitated by our uniqe, behaviour based zebrafish screening technology.

Indication Product Drug discovery Preclinical Phase I Phase II Phase III
ADHD 3Z-20-001
ADHD 3Z-20-002
ADHD 3Z-20-003
ADHD 3Z-20-004
Parkinson's TBA
Schizoprenia TBA
EDS TBA